 Disease Progression
"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 13 | 13 | | 1999 | 0 | 13 | 13 | | 2000 | 0 | 14 | 14 | | 2001 | 0 | 12 | 12 | | 2002 | 0 | 16 | 16 | | 2003 | 0 | 33 | 33 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 38 | 38 | | 2006 | 1 | 41 | 42 | | 2007 | 2 | 53 | 55 | | 2008 | 2 | 63 | 65 | | 2009 | 4 | 57 | 61 | | 2010 | 4 | 72 | 76 | | 2011 | 7 | 56 | 63 | | 2012 | 3 | 74 | 77 | | 2013 | 4 | 85 | 89 | | 2014 | 6 | 70 | 76 | | 2015 | 8 | 97 | 105 | | 2016 | 10 | 92 | 102 | | 2017 | 10 | 119 | 129 | | 2018 | 6 | 107 | 113 | | 2019 | 12 | 128 | 140 | | 2020 | 3 | 108 | 111 | | 2021 | 10 | 82 | 92 | | 2022 | 0 | 54 | 54 | | 2023 | 2 | 57 | 59 | | 2024 | 31 | 55 | 86 | | 2025 | 6 | 65 | 71 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Chen NC, Shah VN, McQueen RB. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1146-e1152.
-
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. RMD Open. 2026 Feb 11; 12(1).
-
Steck AK, Parikh HM, Triolo TM, Ferrat L, You L, Gottlieb PA, Oram RA, Onengut-Gumuscu S, Krischer JP, Rich SS, Redondo MJ. Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
Morimoto K, Chalmers JD, Burgel PR, Daley CL, De Soyza A, Mauger D, Metersky ML, Zhang X, Li S, Goto Y, Teper A, Fernandez C, Hasegawa N. Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial. Respir Investig. 2026 Mar; 64(2):101357.
-
Fortis S, Comellas AP, Bowler RP, Bhatt SP, Hersh CP, Demeo DL, Kinney G, Silverman EK, Cho MH, Moll M. Relationships between bronchodilator responsiveness, a COPD polygenic risk score, and COPD progression. Respir Med. 2026 Feb; 252:108636.
-
Hickman J, Tsai A, Fullard M, Korsmo M, Forbes E, Aslam S, Baumgartner AJ, Feuerstein JS, Bayram E. Early-Onset Parkinson's Disease: Unique Features and Management Approaches. Curr Neurol Neurosci Rep. 2025 Dec 18; 26(1):3.
-
Park S, Yi JE, Kim SH, Lee BY, Ha H, Barker AJ, Huh H. Abnormal vortex formation by 4D flow MRI as a marker for aortic valve replacement in moderate aortic stenosis: an exploratory study. Open Heart. 2025 Dec 17; 12(2).
-
Holt CA, Niedert C, Gedtal M, Virgili G, Hogg RE, Qureshi R. Prognostic factors for age-related macular degeneration progression: An overview of systematic reviews. Surv Ophthalmol. 2026 May-Jun; 71(3):759-773.
-
Humphries SM, Chung A, Swigris JJ, Oh AS, Walsh SLF, Lynch DA, Goldin JG, Kim GHJ. Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2025 Dec; 225(6):e2432053.
-
Veijola R, Tamura RN, Clasen JL, Elding Larsson H, Warncke K, Steck AK, Haller MJ, Jonsdottir B, Akolkar B, Hagopian WA, Rewers MJ, She JX, Ziegler AG, Krischer JP, Toppari J. Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity. Diabetologia. 2026 Mar; 69(3):643-652.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|